| Literature DB >> 18366772 |
Cheryl M Petersen1, Chris L Zimmermann, Steven Cope, Mary Ellen Bulow, Erinn Ewers-Panveno.
Abstract
BACKGROUND: A cost effective tool for the measurement of trunk reposition sense is needed clinically. This study evaluates the reliability and validity of a new clinical spine reposition sense device.Entities:
Mesh:
Year: 2008 PMID: 18366772 PMCID: PMC2358902 DOI: 10.1186/1743-0003-5-9
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Exclusion Criteria (by self-report)
| Oswestry back pain scores of greater than or equal to 5% |
| Balance, coordination, or stabilization therapy within the last six months |
| Excessive use of pain medication, drugs, or alcohol |
| Ligamentous injury to the hips, pelvis, or spine |
| Spinal surgery |
| Balance disorders secondary to: active or recent ear infections, vestibular disorders, trauma to the vestibular canals, or orthostatic hypotension |
| Neurologic disorders including: multiple sclerosis (MS), cerebral vascular accident (CVA), spinal cord injury, neuropathies, and myopathies |
| Diseases of the spine including: osteoporosis, instability, fractures, rheumatoid arthritis (RA), degenerative disc disease (DDD), and spondylolisthesis |
Descriptive Statistics for Subject Characteristics
| 45 | 57 | |
| (Mean ± SD) | 25.6 ± 4.2 | 22.2 ± 3.8 |
| Male:Female | 8 : 37 (21.6%) | 13 : 44 (29.5%) |
| (Mean ± SD) Female, Male | 167.1 ± 7.1, 179.8 ± 8.6 | 167.0 ± 6.5, 181.0 ± 6.2 |
| (Mean ± SD) Female, Male | 58.8 ± 8.6, 86.1 ± 13.9 | 66.4 ± 11.3, 87.3 ± 16.7 |
Figure 1The new measurement method: X and Y coordinates are measured and used in a trigonometric calculation to determine the starting angle. An individual is shown seated in the upright starting posture; during the study, all subjects were blindfolded throughout testing.
Figure 2The new measurement method: The X and Y coordinates are shown above with an individual in a position 2/3 of full flexion; during the study, all subjects were blindfolded throughout testing.
Figure 3Mean reposition error from the target 2/3 position (by trial) for the 45 asymptomatic subjects with the horizontal axis representing trials 1–20 and the vertical axis representing mean reposition error in degrees. Each bar shows the mean reposition error for all the subjects tested (N = 45) for that trial.
Paired Samples T-Test for Portion 2 Test-Retest
| Trial 1 | -.02 | .78 | 0.06 |
| Trial 2 | .10 | 1.03 | 0.02 |
| Trial 3 | .12 | 1.17 | 0.02 |
| Trial 4 | .10 | 1.17 | 0.02 |
| Trial 5 | .13 | 1.16 | 0.01 |
| Trial 6 | .02 | 1.13 | 0.04 |
| Trial 7 | .09 | 1.17 | 0.02 |
Figure 4The Bland Altman plot comparing time one and time two for test-retest reposition mean error degree measures with mean and 95% confidence interval.
Figure 5A plot of line of equality for reposition values comparing the ST6D and the new reposition sense device (degree measurements).
Figure 6The Bland Altman plot comparing the ST6D to the new reposition sense device (degree measurements) with mean and 95% confidence interval.
Mean Degrees ± Standard Deviation for Neutral, Full Flexion and the Two-Thirds (2/3) Flexion Angular Measures for Test (Time One) and Retest (Time Two)
| Neutral | Full Flexion | Two-Thirds Flexion | Percentage of Full Flexion | Neutral | Full Flexion | Two-Thirds Flexion | Percentage of Full Flexion |
| 12.17 ± 1.75 | 47.93 ± 6.43 | 35.95 ± 4.54 | 66.5 | 12.67 ± 1.88 | 48.15 ± 6.65 | 36.64 ± 4.93 | 67.6 |